Zaderej Karen L. 4
4 · EyePoint Pharmaceuticals, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Zaderej Karen L.
Director
Transactions
- Purchase
Common Stock
2025-05-19$5.99/sh+5,000$29,950→ 36,500 total - Purchase
Common Stock
2025-05-16$5.81/sh+5,000$29,050→ 31,500 total